| Dec 12 2024 |
GoodRx Agrees to Pay $25 Million Settlement for Privacy Violations |
Hunton Andrews Kurth |
| Dec 12 2024 |
Trending in Telehealth: November 19 – 25, 2024 |
McDermott Will & Schulte LLP |
| Dec 11 2024 |
Massachusetts Implements Long-Awaited Licensing Regime for Out-of-State Pharmacies |
McDermott Will & Schulte LLP |
| Dec 11 2024 |
Lawsuit Alleges Intentional Sale of “Harmful and Addictive” Ultra-Processed Foods |
Keller and Heckman LLP |
| Dec 11 2024 |
This Week in 340B: December 3 – 9, 2024 |
McDermott Will & Schulte LLP |
| Dec 11 2024 |
EPA Announces Proposed Rule to Revoke Most Food Uses of the Insecticide Chlorpyrifos |
Bergeson & Campbell, P.C. |
| Dec 11 2024 |
Antibody Drug Conjugates Keep Growing: What You Need to Know |
Foley & Lardner LLP |
| Dec 10 2024 |
New Jersey Cannabis Law Does Not Imply a Private Right of Action for Job Applicants Who are Denied Employment Due to Cannabis Use |
Stark & Stark |
| Dec 10 2024 |
Cannabis & Trademarks: Protecting Your Stash |
Bradley Arant Boult Cummings LLP |
| Dec 10 2024 |
Post-Election Outlook: Issues to Watch for Pharmacy Industry Stakeholders |
McDermott Will & Schulte LLP |
| Dec 10 2024 |
USDA and FDA Seek Information About Food Date Labeling |
Keller and Heckman LLP |
| Dec 9 2024 |
Summary of Lytle v. Nutramax Labs., Inc., 114 F.4th 1011 (9th Cir. 2024) |
Sheppard, Mullin, Richter & Hampton LLP |
| Dec 6 2024 |
FDA’s Nutrition Labeling Rule Advances to OMB Amid Senate Hearing on Diabetes and Obesity |
Keller and Heckman LLP |
| Dec 6 2024 |
Healthcare Regulatory Update: DEA Extends Pandemic-Era Telehealth Prescribing Flexibilities Through 2025 |
Nelson Mullins |
| Dec 6 2024 |
CRS Updates Report on Gene-Edited Plants: Regulation and Issues for Congress |
Bergeson & Campbell, P.C. |
| Dec 5 2024 |
District Court Approves Consent Decrees Establishing Deadlines for Completing TSCA Risk Evaluations |
Bergeson & Campbell, P.C. |
| Dec 5 2024 |
FDA Releases Long-Anticipated Guidance on Predetermined Change Control Plans for Devices That Utilize AI/ML Software |
Sheppard, Mullin, Richter & Hampton LLP |
| Dec 5 2024 |
Goin’ Down South: How the Southeastern U.S. Became the Current Hotbed of Cannabis Activity |
Bradley Arant Boult Cummings LLP |
| Dec 5 2024 |
District Court Grants Summary Judgment in Part to Plaintiffs, Vacating and Remanding Final SECURE Rule to USDA |
Bergeson & Campbell, P.C. |
| Dec 4 2024 |
Overcoming Patent Challenges for AI/ML-Assisted Life Sciences (TechBio) Inventions: Strategies for Navigating Section 101 at the US Patent & Trademark Office |
Mintz |
| Dec 4 2024 |
O-H-N-O: Big Trouble in Little Columbus? |
Bradley Arant Boult Cummings LLP |
| Dec 4 2024 |
Telehealth Update: DEA/HHS Temporary Rule, Medicare Coverage of Telehealth Services, Potential for Increased Oversight, and What to Watch For in 2025 |
Mintz |
| Dec 4 2024 |
Members of Congress Urge FDA to Ban Red 3 |
Keller and Heckman LLP |
| Dec 4 2024 |
This Week in 340B: November 19 – December 2, 2024 |
McDermott Will & Schulte LLP |
| Dec 3 2024 |
Supplement to the 2022 Food Code |
Sheppard, Mullin, Richter & Hampton LLP |
| Dec 3 2024 |
CIPL Responds to DOJ NPRM on Bulk Transfers of Americans’ Sensitive Personal Data |
Hunton Andrews Kurth |
| Dec 3 2024 |
FDA Issues Draft Guidance on Infant Formula Manufacture Discontinuance or Disruption Notifications |
Keller and Heckman LLP |
| Dec 3 2024 |
Can the President Impose Tariffs without Congressional Approval? |
Miller Canfield |
| Dec 3 2024 |
APHIS Revises and Adds Exemptions for Plants Modified or Produced through Genetic Engineering |
Bergeson & Campbell, P.C. |
| Dec 3 2024 |
NJ’s Mixed Smoke Signals: Cracking Down on Hemp but Stalling on Cannabis Lounges |
Norris McLaughlin P.A. |
| Dec 3 2024 |
Latest updates on Per- and Polyfluorinated Substances (PFAS) in Europe |
Squire Patton Boggs (US) LLP |
| Dec 2 2024 |
New York Enacts Laws to Enhance Restaurant Health and Safety Standards |
Greenberg Traurig, LLP |
| Dec 2 2024 |
Federal Court Rules That Illegal Acts Are Legal Because They Are Illegal: Cannabis Law in a Nutshell |
Bradley Arant Boult Cummings LLP |
| Dec 2 2024 |
Navigating Regulatory Challenges in the Dietary Supplement Industry: Insights on NJ Assembly Bill No. 1848 |
Epstein Becker & Green, P.C. |
| Dec 2 2024 |
GLP-1 Drugs: Brand Companies Push FDA to Limit Compounding |
Foley & Lardner LLP |
